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a b s t r a c t
Objective: Orthodontic tooth movement (OTM) is achieved by alveolar bone remodelling
induced by mechanical loading. Whilst interleukin-1 (IL-1) is directly involved in OTM, the
role of interleukin-1 receptor antagonist (IL-1Ra), a naturally occurring IL-1 antagonist, is not
completely defined. Therefore, the aim of this study was to investigate the effects of IL-1Ra
on OTM.
Methods: An orthodontic appliance was placed in C57BL6 mice treated with vehicle or IL-1Ra
(10 mg/kg/day). OTM and TRAP-positive osteoclasts were evaluated after 12 days of me-
chanical loading and the levels of cytokines on periodontal tissues were analysed by ELISA
after 12 and 72 h.
Results: Mice treated with IL-1Ra showed diminished OTM and decreased numbers of TRAP-
positive osteoclasts. In line with this, lower levels of IL-1b and TNF-a, and higher levels of IL-
10, were observed on periodontal tissues of IL-1Ra-treated mice in relation to the vehicle-
treated group.
Conclusion: The present study suggests that IL-1Ra downregulates OTM, probably by its anti-
inflammatory actions.
# 2011 Elsevier Ltd. 
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Orthodontic tooth movement (OTM) occurs through remodel-
ling of alveolar bone after mechanical stimuli. The orthodontic
forces generate and propagate signalling cascades through all
paradental tissue cells, triggering important changes in the
homeostatic periodontal environment.1,2* Corresponding author at: Departamento de Clı´nica, Patologia e Cirurg
de Minas Gerais, Av. Presidente Antoˆ nio Carlos 6627, CEP 31.270-901,
fax: +55 31 3409 2430.
E-mail addresses: tarcilia@ufmg.br, silva.tarcilia@gmail.com (T.A. 
0003–9969      # 2011 Elsevier Ltd. 
doi:10.1016/j.archoralbio.2011.09.018
Open access under the Elsevier OA license.The orthodontic loading leads to a focal tissue injury and,
consequently, an aseptic inflammatory response charac-
terised by the release of several important inflammatory
mediators on periodontal tissues,2,3 such as the cytokine
interleukin-1 (IL-1).4 IL-1 is directly involved in bone resorption
by taking part in the survival, fusion and activation of
osteoclasts and it exerts its activities by binding to two types
of receptors, IL-1-RI and IL-1-RII.5 Whilst the latter has noia Odontolo´gicas, Faculdade de Odontologia, Universidade Federal
 Belo Horizonte, Minas Gerais, Brazil. Tel.: +55 31 3409 2478;
Silva).
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IL-1, the former develops pro-inflammatory functions, such as
cell recruitment and release of other cytokines, which also are
involved in bone resorption.6 However, IL-1 functions are
physiologically controlled by the naturally occurring interleu-
kin-1 receptor antagonist (IL-1Ra), which competitively blocks
the interactions of IL-1 with its receptors and inhibits its
activity.7,8
IL-1Ra has long been studied in clinical and experimental
surveys as a physiological and therapeutic target in inflam-
matory conditions related to bone resorption, such as
rheumatoid arthritis9,10 and periodontal disease.11,12 These
studies reported that administration of exogenous IL-1Ra may
be a useful strategy to control bone resorption, mainly for its
anti-inflammatory properties related to the antagonism of IL-
1.9–11,13 However, only a few studies have investigated the
effect of IL-1Ra on OTM, showing a positive correlation
between decreased IL-1Ra gingival expression and faster
OTM in humans.14–17
Despite these findings, there is a lack of evidence describing
the effects of IL-1Ra therapy on bone remodelling after
mechanical loading. Therefore, the aim of this study was to
investigate the effects of IL-1Ra administration on OTM in a
mouse model.
2. Materials and methods
2.1. Experimental animals
Thirty five ten-week-old wild-type mice (WT) (C57BL6/J) were
used in this study. For histomorphometric analysis, 10 mice
with orthodontic appliance were used. In this set of experi-
ments, the left side of maxillae (without orthodontic appli-
ance) was used as control. For biochemical analysis, 20 mice
received the orthodontic appliance and treatments described
below, and 5 mice did not receive appliance, being used as the
control group. All animals were treated under ethical regula-
tions for animal experiments, defined by the Institutional
Ethics Committee. Each animal’s weight was recorded
throughout the experimental period and there was no
significant loss of weight.
2.2. Experimental protocol
The experimental protocol was based on a previous study.18
Briefly, mice were anaesthetized and a Ni–Ti
0.25 mm  0.76 mm coil spring (Lancer Orthodontics, San
Marcos, CA, USA) was bonded by a light-cured resin
(Transbond, Unitek/3M, Monrovia, CA, USA) between the
maxillary right first molar and the incisors. The force
magnitude was calibrated by a tension gauge (Shimpo
Instruments, Itasca, IL, USA) to exert a force of 0.35 N applied
in the mesial direction. There was no reactivation during the
experimental period. Thereafter, mice were randomly divided
in two groups for histomorphometric analysis: mice treated
with vehicle (PBS) (vehicle group) or with IL-1Ra (daily
administration [s.c.] of 10 mg/kg/day IL-1Ra [Biogen INC;
Geneva, Switzerland]) (IL-1Ra group). For biochemical assays,
three groups were created: mice without appliance (controlgroup) and mice with activated coil spring (experimental
group) treated with PBS (vehicle group) or with IL-1Ra (IL-1Ra
group). At the end of the experiments, mice were euthanized
with an overdose of anaesthetic at the following times: 12 days
after orthodontic appliance placement for histological mea-
surements, and 12 h and 72 h for biochemical analysis. For
every set of experiments, 5 mice/group were used for each
time-point.
2.3. Histopathological analysis
The right and left halves of maxillae, including first, second, and
third molars, were dissected, fixed in 10% buffered formalin (pH
7.4) and rinsed in distilled water. Thereafter, each hemi-maxilla
was decalcified in 14% EDTA (pH 7.4) for 14 days and embedded
in paraffin. Samples were cut into sagittal sections of 5 mm
thickness. Sections were stained for tartrate-resistant acid
phosphatase (TRAP; Sigma–Aldrich, St. Louis, MO, USA),
counterstained with haematoxylin, and used for histological
examination. The first molar distobuccal root, on the coronal
two-thirds of the mesial periodontal site, was used for osteoclast
counting on 5 non-consecutive sections (40 mm apart one from
the other) per mouse. Osteoclasts were identified as TRAP-
positive, multinucleated cells on the bone resorption lacunae.
2.4. Measurement of tooth movement
Image J software (National Institutes of Health) was used to
quantify the amount of tooth movement, as previously
described.18 Tooth movement was obtained through the
difference between the distance of the cementum-enamel-
junction’s (CEJ’s) of the first molar and the second molar (1st and
2nd molar distance) of the experimental side (right hemi-
maxila) in relation to the control side (left hemi-maxila) of the
same animal. Five sections per mouse were evaluated under a
microscope Axioskop 40 (Carl Zeiss, Go¨ttingen, Niedersachsen,
Germany) adapted to a digital camera (PowerShot A620, Canon,
Tokyo, Honshu, Japan). Three measurements were conducted
for each evaluation and the variability was below 5%.
2.5. Measurement of cytokine levels
Periodontal ligament and surrounding alveolar bone samples
from the areas adjacent to the upper first molars were obtained
using a stereomicroscope. Samples were weighed and homoge-
nized in PBS (0.4 mM NaCl and 10 mM NaPO4) containing
protease inhibitors (0.1 mM PMSF, 0.1 mM benzethonium
chloride, 10 mM EDTA, and 0.01 mg/mL aprotinin A) and 0.05%
Tween-20 at 1 mg/mL. The homogenate was centrifuged
(8946  g) at 4 8C for 10 min. The supernatant was then collected
and stored at 70 8C until further analysis. The levels of IL-1b,
TNF-aandIL-10wereevaluatedbydouble-ligandenzyme-linked
immunosorbent assay (ELISA), according to the manufacturer’s
protocol (R&DSystems,Minneapolis,MN,USA).  Theresults were
expressed as picograms of cytokine/100 mg of tissue.
2.6. Statistical analysis
The results were expressed as the mean  standard error of
the mean (SEM). Comparison amongst the groups was
Fig. 1 – (A) Amount of tooth movement in PBS (vehicle) and IL-1Ra treated mice (IL-1Ra). (B) Number of TRAP-positive
osteoclasts in both groups. *P < 0.05 comparing control group to the respective experimental group. #P < 0.05 comparing
vehicle- and IL-1Ra-treated experimental groups. One-way ANOVA and Newman–Keuls multiple comparison test.
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(ANOVA), followed by the Newman–Keuls multiple compari-
son test. P < 0.05 was considered statistically significant.
3. Results
3.1. Tooth movement and TRAP-positive cells
The amount of OTM was significantly less in mice treated with
IL-1Ra (Fig. 1A), as well as the number of TRAP-positive
osteoclasts (Fig. 1B), when compared to the vehicle group after
12 days of mechanical loading.
Histological characterisation of periodontal tissues also
revealed that IL-1Ra treated mice demonstrated a decreased
TRAP activity and a smaller number of osteoclasts in the
pressure side of the periodontium (Fig. 2E and F), when
compared to the experimental tooth of vehicle treated mice
(Fig. 2C and D).
3.2. Levels of cytokines in periodontal tissues
The smaller amount of OTM observed in IL-1Ra treated mice
led us to investigate the effects of such therapy on the
expression of cytokines involved in bone remodelling.
Mechanical loading applied to tooth triggered a significant
release of pro-inflammatory and bone resorptive cytokines in
periodontal tissues just after 12 h of stimulation. Whilst the
levels of IL-1b (Fig. 3A) and TNF-a (Fig. 3B) increased
approximately 6 and 5.5 fold, respectively, IL-10 levels
(Fig. 3C) were not altered when compared to control mice.
After 72 h of mechanical loading, IL-1b levels were almost 10
times higher than control (Fig. 3A), and the levels of TNF-a
(Fig. 3B) and IL-10 (Fig. 3C) were similar to the basal condition.
In contrast, treatment of mice with IL-1Ra reduced the
inflammatory milieu observed in periodontal tissues after
stimuli. IL-1Ra therapy induced a decrease of 66% and 76% in
the levels of IL-1b (Fig. 3A) and TNF-a (Fig. 3B), respectively,
when compared to vehicle-treated mice, whilst the levels of
IL-10 (Fig. 3C) enhanced approximately 2 fold either at 12 or at
72 h after mechanical loading.4. Discussion
Interleukin-1 (IL-1) has been one of the most studied cytokines
and it is one of the major soluble proteins related to osteoclast
activation and bone resorption.5,6 Evidence for the existence of
IL-1 controlling pathways indicates that the IL-1 receptor
antagonist (IL-1Ra) can be important for the in vivo regulation
of IL-1b activity in bone resorptive conditions.9–11 However,
the effect of IL-1Ra on bone remodelling after mechanical
loading is not well described. In the present study, adminis-
tration of IL-1Ra diminished OTM by reducing the expression
of the pro-inflammatory cytokines IL-1b and TNF-a, and by
increasing the levels of IL-10, a negative regulator of bone
resorption.
When an orthodontic force is applied on teeth, it leads to a
transient aseptic inflammation of the periodontium that
culminates in bone remodelling.1 In this context, bone
resorption is a fundamental step and several cytokines
associated to osteoclast differentiation and activation, such
as TNF-a and IL-1b, are early released in the periodontium
after mechanical loading.3,4,18–20 Accordingly, the levels of
these cytokines were increased in our experimental condi-
tions, whilst the levels of IL-10, a cytokine known to control
bone resorption and osteoclast activation,21 were not affected.
In view of the importance of this inflammatory milieu to
bone resorption, it has been suggested that the control of such
inflammation could affect OTM. A previous study showed that
an interference with TNF-a activity might decrease osteoclast
migration and, consequently, diminish OTM.18 In this regard,
administration of IL-1Ra to interfere with IL-1b activity could
also alter mechanically induced bone remodelling. IL-1Ra, first
called IL-1 inhibitor, was cloned and identified as an IL-1
receptor antagonist after being noticed to bind to IL-1
receptors but not to transduce the same signals that IL-1b
did.22,23 Thus, IL-1Ra acts by competitively blocking the
interactions of IL-1 to their receptors, inhibiting its activi-
ties.7,8 Indeed, the administration of exogenous IL-1 receptor
antagonist has been shown to be effective in reducing signs of
IL-1-related bone resorptive conditions, such as rheumatoid
arthritis10 and periodontal disease,11 concomitantly with a
Fig. 2 – Histological changes related to OTM in vehicle- and IL-1Ra-treated mice. (A and B) Control group (without mechanical
loading). (C and D) Experimental vehicle-treated and (E and F) experimental IL-1Ra treated groups (12 days after mechanical
loading). Panels (B), (D) and (F) represent the higher view of the identified area in (A), (C) and (E), respectively. Large arrows
indicate TRAP-positive osteoclasts. MB, mesial alveolar bone; DB, distal alveolar bone; PL, periodontal ligament; R, root.
Small arrows indicate the direction of tooth movement. Bar = 100 mm.
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decreased physiological IL-1Ra expression in gingival crevi-
cular fluid has been shown to correlate with faster OTM in
humans.14–17
In the present study, mice treated with IL-1Ra showed
significantly diminished OTM and osteoclast numbers than
vehicle-treated animals. This phenotype was associated with
reduced early release of TNF-a and IL-1b, concomitantly to
increased expression of IL-10 on periodontal tissues. The
present results give support to previous findings showing that
administration of soluble IL-1 receptors reduces the amount of
OTM in rats24 and go further when showing that this effect
occurs by controlling the expression of cytokines. The data
strongly indicates that interfering with the IL-1b pathway mayimpair the pro-inflammatory and pro-osteoclastic milieu on
periodontal tissues, and, consequently, decrease OTM. In
accordance, in vitro studies have shown that IL-1 receptor
antagonists can inhibit the compressive force-induced ex-
pression of RANKL (receptor activator of nuclear factor kappa
B ligand), a positive regulator of osteoclast differentiation and
activation, by periodontal ligament cells.25 Similarly, the
expression of TNF-a after application of compressive forces
in vitro was decreased with the addition of IL-1Ra to cell
cultures.26
In conclusion, the present study suggests that IL-1Ra might
affect bone remodelling after mechanical loading probably by
its anti-inflammatory actions, such as the reduction of pro-
inflammatory and bone resorptive cytokines and the increase
Fig. 3 – Mean concentrations of (A) IL-1b, (B) TNF-a and (C)
IL-10 in periodontal tissues of control (without mechanical
loading), experimental vehicle-treated (vehicle) and
experimental IL-1Ra treated (IL-1Ra) groups after 12 h and
72 h of mechanical loading. *P < 0.05 comparing control
group to the respective experimental group. #P < 0.05
comparing vehicle and IL-1Ra experimental groups. One-
way ANOVA and Newman–Keuls multiple comparison
test.
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data provides new insights into the development of future
therapeutic interventions with IL-1Ra, which could modulate
the amount of OTM and restrain the relapse of the final
orthodontic result.Funding: This work was supported by Fundac¸a˜o de Amparo a
Pesquisas do Estado de Minas Gerais (FAPEMIG, Brazil), Coor-
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